A Successful Live Birth Through In Vitro Fertilization and Embryo Transfer in Stage IVb Endometrial Carcinoma after Conservative Treatment: a Case Report

Author:

Xiao Zerui1,Song Ziyi1,Zhao Yuexin1,Wang Yiqin1,Li Xiaoping1,Liang Rong1,Wang Jianliu1,lu Qun1

Affiliation:

1. Peking University People's Hospital

Abstract

Abstract Introduction An increasing number of young patients with early-stage endometrial cancer are opting for fertility-sparing treatment, and they have achieved reassuring rates of complete remission, with some women achieving pregnancy. However, surgical treatment is still recommended for patients with advanced endometrial cancer. We reported a woman with IVb endometrial cancer (EC) who reached complete remission (CR) and gained a live birth successfully with the help of in vitro fertilization and embryo transfer (IVF-ET). Case report A 30-year-old woman found to have stage IVb EC after hysteroscopy, laparoscopy, and pathological examination. After a combination of chemotherapy and progesterone therapy, the woman achieved complete remission. The woman became pregnant with IVF-ET and got a full-term live birth. In addition, there was no recurrence after 19 months of observation. The molecular classification of POLE and the combination of chemotherapy and progesterone therapy may be associated with a good prognosis of this patient. The use of progestin-primed ovarian stimulation (PPOS) and the combination of letrozole and levonorgestrel-releasing intrauterine device (LNG-IUD) during ovulation induction seemed to be safe for the woman Conclusion This is the first report on fertility-sparing treatment and live birth for advanced EC. IVF-ET is feasible for women with EC who preserve reproductive function. The progestin-primed ovarian stimulation combined with levonorgestrel-releasing intrauterine device and letrozole seems to be safe for these women. Patients still need to be closely watched for tumor recurrence.

Publisher

Research Square Platform LLC

Reference28 articles.

1. Fertility-sparing management for endometrial cancer: review of the literature;Garzon S;Minerva Med,2021

2. National Comprehensive Cancer Network. (NCCN) Clinical Practice Guidelines in Oncology. Endometrial Carcinoma, Version 1. 2022. https://www.nccn.org/login?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf. Accessed 15 Sept 2022. In.

3. Xiao Z, Song Z, et al. Pregnancy outcomes after fertility preservation in women with endometrial carcinoma and atypical endometrial hyperplasia: A systematic review and meta-analysis. Gynecology and Obstetrics Clinical Medicine; 2021.

4. Cicinelli E, Tinelli R et al. Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study. Menopause. 2010 May-Jun;17(3):511-5. 10.1097/gme.0b013e3181c8534d. PMID: 20081548.

5. Whether preoperative hysteroscopy increases the dissemination of endometrial cancer cells: A systematic review and meta-analysis;Dong H;J Obstet Gynaecol Res,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3